Delivery Order SPE2DB22D2206-SPE2DB25FEZ39
Award Date
1/6/25
Potential Completion Date
1/7/25
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,317.92, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product. This is a firm fixed-price delivery order contract with an ultimate completion date of December 27, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $78,297.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product.
The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX4CM, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $3,212.70, is a delivery order for the supply of 4,566,174,150 units of CATHFLO ACTIVASE 2 MG VIALS. This contract does not have a set-aside designation, indicating open competition.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award, with ID SPE2DB20D1109|SPE2DB22FN81M, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,466.25 firm-fixed-price delivery order is for the supply of 4556591127 units of the medication CATHFLO ACTIVASE 2 MG VIALS. The contract has an ultimate completion date of March 17, 2022.
Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award, identified as SPE2DB22D2206|SPE2DB25FDY76, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of 4566242132 CATHFLO ACTIVASE 2 MG VIALS. The contract has a firm fixed price of $2,579.34 and an ultimate completion date of October 29, 2024. It is not designated as a set-aside contract.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,070.76 delivery order contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical medical product, to support military healthcare programs.
The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,922.92 Firm Fixed Price Delivery Order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the...
This federal contract award, with a value of $2,042.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a completion date of September 28, 2023. This contract is a delivery order, with a firm fixed price pricing type.
The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award, ID SPE2DB22D3501|SPE2DB24FWE29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation. The $5,140.32 firm-fixed-price delivery order is for the supply of 4565121810 - CATHFLO ACTIVASE 2 MG VIALS, with a period of performance through July 8, 2024.
Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $3,353.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a period of performance through July 16, 2024.
Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...